1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol and Metastase

1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol has been researched along with Metastase in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiang, JH; Chung, JG; Hour, MJ; Lin, MW; Tsai, SC; Tsuzuki, M; Wu, HC; Wu, JB; Yang, JS	1

Other Studies

1 other study(ies) available for 1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol and Metastase

Article	Year
Antitumor effects of the novel quinazolinone MJ-33: inhibition of metastasis through the MAPK, AKT, NF-κB and AP-1 signaling pathways in DU145 human prostate cancer cells. International journal of oncology, 2012, Volume: 41, Issue:4 Topics: Cell Adhesion; Gene Expression Regulation, Neoplastic; Glycerophosphates; Humans; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Metastasis; NF-kappa B; Oncogene Protein v-akt; Prostatic Neoplasms; Quinazolinones; Signal Transduction; Transcription Factor AP-1	2012

Article

Year

Antitumor effects of the novel quinazolinone MJ-33: inhibition of metastasis through the MAPK, AKT, NF-κB and AP-1 signaling pathways in DU145 human prostate cancer cells.

International journal of oncology, 2012, Volume: 41, Issue:4

Topics: Cell Adhesion; Gene Expression Regulation, Neoplastic; Glycerophosphates; Humans; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Metastasis; NF-kappa B; Oncogene Protein v-akt; Prostatic Neoplasms; Quinazolinones; Signal Transduction; Transcription Factor AP-1

2012